1️⃣ The U.S. National Institute of Allergy and Infectious Diseases (NIAID) is funding the lab creation of deadly, genetically engineered bird-flu viruses—even as its director, Dr. Jeffery Taubenberger, is named as an inventor on the U.S. patent for the vaccine platform designed to counter them.
2️⃣ In other words, the same agency making new bird-flu viruses is led by the man who could profit from the vaccine meant to fight them.
Mainstream reports confirm Taubenberger can receive royalties if the vaccine succeeds—up to $150,000 per year under federal law.
3️⃣ This overlap between virus creation and vaccine ownership raises profound conflict-of-interest and national-security concerns.
The official overseeing pandemic-grade bird-flu research also stands to earn personal income from the vaccine platform his agency is financing.
4️⃣ Under President Trump, HHS and NIH launched “Generation Gold Standard,” a $500 million program focused on new “universal” bird-flu vaccines.
Dr. Taubenberger’s patented BPL vaccine technology sits at the core of that project.
5️⃣ A Science report confirmed NIH “has two patents for the BPL-inactivated universal flu vaccine,” that Taubenberger “is named as one of the inventors,” and that he “stands to financially benefit” from the program.
6️⃣ Put plainly:
The federal official directing America’s bird-flu virus research is also positioned to earn royalties from the vaccine platform his own agency is funding—tying his financial interests directly to the emergence of a bird-flu pandemic.
7️⃣ Meanwhile, the same playbook that preceded COVID-19 is playing out again:
🔹 Create new pathogens
🔹 Classify and conceal risky projects
🔹 Push “pandemic preparedness” programs
🔹 Roll out taxpayer-funded vaccines
8️⃣ Just this year alone, NIAID-funded labs have created:
-A chimeric H5N1 virus that infects human lung cells & resists drugs
-A hybrid H5N1 virus 100% lethal in mammals
-Bat–human hybrid flu viruses resistant to antivirals
-Engineered bird-flu strains rebuilt from synthetic gene clones
9️⃣ The outcome is a closed loop:
Government-funded pathogen creation feeding government-funded vaccine development—run by the same people who own the vaccine patents.
🔟 Dr. Jeffery Taubenberger, who famously resurrected the 1918 “Spanish flu,” now leads the agency driving gain-of-function bird-flu research and holds the patent to the vaccine that could follow.
⚠️ According to Science and federal filings, Taubenberger could personally earn up to $150,000 a year in royalties from that vaccine platform—while his agency funds the very viruses it targets.
💬 Bottom line:
The U.S. government’s pandemic apparatus has merged research, regulation, and remuneration.
The question is no longer whether the next outbreak is being planned for—but whether it’s being prepared for profit.